{(1R,3R,4R,5S)-4-[(α-L-fucopyranosyl)oxy]-1-methoxycarbonyl-5-methylcyclohex-3-yl} 2-O-benzoyl-3-O-[(1S)-1-carboxy-2-cyclohexylethyl]-β-D-galactopyranoside | 1026073-56-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: {(1R,3R,4R,5S)-4-[(α-L-fucopyranosyl)oxy]-1-methoxycarbonyl-5-methylcyclohex-3-yl} 2-O-benzoyl-3-O-[(1S)-1-carboxy-2-cyclohexylethyl]-β-D-galactopyranoside
• 英文别名: (2S)-2-[(2R,3S,4S,5R,6R)-5-benzoyloxy-3-hydroxy-2-(hydroxymethyl)-6-[(1R,2R,3S,5R)-5-methoxycarbonyl-3-methyl-2-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxyoxan-4-yl]oxy-3-cyclohexylpropanoic acid
• CAS: 1026073-56-2
• 化学式: C₃₇H₅₄O₁₆
• 分子量: 754.826
• InChiKey: PFMCSUTVZDQAQF-WRUFZHIWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  53
• 可旋转键数：
  15
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.76
• 拓扑面积：
  237
• 氢给体数：
  6
• 氢受体数：
  16

反应信息

• 作为反应物：
  描述：

  {(1R,3R,4R,5S)-4-[(α-L-fucopyranosyl)oxy]-1-methoxycarbonyl-5-methylcyclohex-3-yl} 2-O-benzoyl-3-O-[(1S)-1-carboxy-2-cyclohexylethyl]-β-D-galactopyranoside 在 copper(ll) sulfate pentahydrate 、 四丁基氟化铵 、 1-羟基苯并三唑 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 sodium ascorbate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 水 、 N,N-二甲基甲酰胺 、 叔丁醇 为溶剂， 反应 5.08h， 生成 (1R,3R,4R,5S)-3-[2-O-benzoyl-3-O-((1S)-1-carboxy-2-cyclohexylethyl)-(β-D-galactopyranosyl)oxy]-4-[(α-L-fucopyranosyl)oxy]-5-methyl-N-(4-{1-[(6-nitro-1H-indol-3-yl)methyl]-1H-1,2,3-triazol-4-yl}butyl)cyclohexanecarboxamide
  参考文献：
  名称：

  Nanomolar E-Selectin Antagonists with Prolonged Half-Lives by a Fragment-Based Approach

  摘要：

  Selectins, a family of C-type lectins, play a key role in inflammatory diseases (e.g., asthma and arthritis). However, the only millimolar affinity of sialyl Lewis(x) (sLe(x)), which is the common tetrasaccharide epitope of all physiological selectin ligands, has been a major obstacle to the development of selectin antagonists for therapeutic applications. In a fragment-based approach guided by NMR, ligands binding to a second site in close proximity to a sLe(x) mimic were identified. A library of antagonists obtained by connecting the sLe(x) mimic to the best second-site ligand via triazole linkers of different lengths was evaluated by surface plasmon resonance. Detailed analysis of the five most promising candidates revealed antagonists with K-D values ranging from 30 to 89 nM. In contrast to carbohydratelectin complexes with typical half-lives (t(1/2)) in the range of one second or even less, these fragment-based selectin antagonists show t(1/2) of several minutes. They exhibit a promising starting point for the development of novel anti-inflammatory drugs.

  DOI：

  10.1021/ja4029582
• 作为产物：
  描述：

  {(1R,3R,4R,5S)-4-[(2,3,4-tris-O-benzyl-6-deoxy-α-L-galactopyranosyl)oxy]-1-methoxycarbonyl-5-methylcyclohex-3-yl} 2,4,6-tri-O-benzoyl-3-O-[(1S)-1-benzyloxycarbonyl-2-cyclohexylethyl]-β-D-galactopyranoside 在 palladium hydroxide on carbon 氢气 、 甲醇 、 sodium methylate 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 水 、 甲醇 为溶剂， 20.0 ℃ 、400.01 kPa 条件下， 反应 62.0h， 以76%的产率得到{(1R,3R,4R,5S)-4-[(α-L-fucopyranosyl)oxy]-1-methoxycarbonyl-5-methylcyclohex-3-yl} 2-O-benzoyl-3-O-[(1S)-1-carboxy-2-cyclohexylethyl]-β-D-galactopyranoside
  参考文献：
  名称：

  Glycomimetic replacements for hexoses and N-acetyl hexosamines

  摘要：

  提供了一种获取寡糖类模拟物的化合物和方法。更具体地，描述了一种通过在环己烷衍生物中合并或替代来获得寡糖类模拟物的化合物和方法。

  公开号：

  US20080161546A1

文献信息

• [EN] HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS<br/>[FR] INHIBITEURS HÉTÉROBIFONCTIONNELS D'E-SÉLECTINES ET DE RÉCEPTEURS AUX CHIMIOKINES CXCR4
  申请人：GLYCOMIMETICS INC

  公开号：WO2010126888A1

  公开（公告）日：2010-11-04

  Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood. More specifically, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described.

  提供了用于治疗癌症和炎症性疾病的化合物、组合物和方法，以及释放细胞（如干细胞，例如骨髓祖细胞）进入循环血液并增强细胞在血液中的保留。具体描述了同时抑制E-选择素和CXCR4趋化受体的异二功能化合物。
• [EN] E-SELECTIN ANTAGONISTS<br/>[FR] ANTAGONISTES DE L'E-SÉLECTINE
  申请人：GLYCOMIMETICS INC

  公开号：WO2012037034A1

  公开（公告）日：2012-03-22

  Compounds, compositions and methods are provided for inhibiting in vitro and in vivo processes mediated by E-selectin binding. More specifically, particular glycomimetic compounds are described, wherein the compounds are E- selectin antagonists.

  提供了抑制E-选择素结合介导的体内外过程的化合物、组合物和方法。更具体地，描述了特定的糖类拟态化合物，其中这些化合物是E-选择素拮抗剂。
• [EN] GLYCOMIMETIC-PEPTIDOMIMETIC INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS<br/>[FR] INHIBITEURS GLYCOMIMÉTIQUES-PEPTIDOMIMÉTIQUES DE SÉLECTINES E ET DE RÉCEPTEURS DE CHIMIOKINE CXCR4
  申请人：GLYCOMIMETICS INC

  公开号：WO2012061662A9

  公开（公告）日：2012-12-06